Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Biomedical Nanotechnology|May 21, 2015
Testing nanoparticles for angiogenesis-related disease: charting the fastest route to the clinicChristopher D Sarsons, Amy Tekrony, Kristin Yaehne, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 21, 2016
Quantum dot interactions and flow effects in angiogenic zebrafish (Danio rerio) vessels and human endothelial cellsXiao-Yu Jiang, Christopher D Sarsons, M Juliana Gomez-Garcia, et al.
Biomedicines|October 28, 2023
Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle CellsChristopher D Sarsons, Dean Gilham, Laura M Tsujikawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2016
Tailoring nanoparticle designs to target cancer based on tumor pathophysiologyEdward A Sykes, Qin Dai, Christopher D Sarsons, et al.
International Immunopharmacology|March 1, 2023
Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammationLi Fu, Dean Gilham, Stephanie C Stotz, et al.
RSC Advances|May 11, 2022
Surface-grafted polyethylene glycol conformation impacts the transport of PEG-functionalized liposomes through a tumour extracellular matrix modelHagar I Labouta, M Juliana Gomez-Garcia, Christopher D Sarsons, et al.
Biomedicines|June 28, 2023
Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal ImpairmentDean Gilham, Sylwia Wasiak, Brooke D Rakai, et al.
Atherosclerosis|November 27, 2018
Apabetalone downregulates factors and pathways associated with vascular calcificationDean Gilham, Laura M Tsujikawa, Christopher D Sarsons, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2022
Breaking boundaries: Pan BETi disrupt 3D chromatin structure, BD2-selective BETi are strictly epigenetic transcriptional regulatorsLaura M Tsujikawa, Olesya A Kharenko, Stephanie C Stotz, et al.
Clinical Epigenetics|July 14, 2019
Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanismLaura M Tsujikawa, Li Fu, Shovon Das, et al.
Pageof 1